HomeCompareSMPFF vs ABBV

SMPFF vs ABBV: Dividend Comparison 2026

SMPFF yields 249.22% · ABBV yields 3.06%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SMPFF wins by $4732920065047.51M in total portfolio value
10 years
SMPFF
SMPFF
● Live price
249.22%
Share price
$0.80
Annual div
$2.00
5Y div CAGR
63.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4732920065047.62M
Annual income
$4,705,545,810,201,515,000.00
Full SMPFF calculator →
ABBV
AbbVie Inc.
● Live price
3.06%
Share price
$217.44
Annual div
$6.65
5Y div CAGR
40.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.3K
Annual income
$24,771.77
Full ABBV calculator →

Portfolio growth — SMPFF vs ABBV

📍 SMPFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSMPFFABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SMPFF + ABBV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SMPFF pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SMPFF
Annual income on $10K today (after 15% tax)
$21,183.80/yr
After 10yr DRIP, annual income (after tax)
$3,999,713,938,671,288,000.00/yr
ABBV
Annual income on $10K today (after 15% tax)
$259.96/yr
After 10yr DRIP, annual income (after tax)
$21,056.00/yr
At 15% tax rate, SMPFF beats the other by $3,999,713,938,671,267,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SMPFF + ABBV for your $10,000?

SMPFF: 50%ABBV: 50%
100% ABBV50/50100% SMPFF
Portfolio after 10yr
$2366460032523.86M
Annual income
$2,352,772,905,100,770,000.00/yr
Blended yield
99.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

SMPFF
No analyst data
Altman Z
2.9
Piotroski
7/9
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+17.8% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SMPFF buys
0
ABBV buys
7
PoliticianChamberTickerTypeAmountDate
Julie Johnson🏢 House$ABBV▼ Sell$1,001 - $15,0002025-12-18
Julia Letlow🏢 House$ABBV▼ Sell$1,001 - $15,0002025-12-08
Julie Johnson🏢 House$ABBV▼ Sell$1,001 - $15,0002025-11-13
Lisa McClain🏢 House$ABBV▼ Sell$1,001 - $15,0002025-10-31
Lisa McClain🏢 House$ABBV▼ Sell$1,001 - $15,0002025-10-30
Lisa McClain🏢 House$ABBV▲ Buy$1,001 - $15,0002025-10-30
John Boozman🏛 Senate$ABBV▼ Sell$1,001 - $15,0002025-08-22
John Boozman🏛 Senate$ABBV▼ Sell$1,001 - $15,0002025-08-22
Julie Johnson🏢 House$ABBV▼ Sell$1,001 - $15,0002025-08-14
John Boozman🏛 Senate$ABBV▼ Sell$1,001 - $15,0002025-08-11
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSMPFFABBV
Forward yield249.22%3.06%
Annual dividend / share$2.00$6.65
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR63.4%40.6%
Portfolio after 10y$4732920065047.62M$102.3K
Annual income after 10y$4,705,545,810,201,515,000.00$24,771.77
Total dividends collected$4731114300199.77M$61.0K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SMPFF vs ABBV ($10,000, DRIP)

YearSMPFF PortfolioSMPFF Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$51,423$40,722.74$11,550$430.00+$39.9KSMPFF
2$374,809$319,786.78$13,472$627.96+$361.3KSMPFF
3$3,960,502$3,559,456.57$15,906$926.08+$3.94MSMPFF
4$61,674,784$57,437,046.94$19,071$1,382.55+$61.66MSMPFF
5$1,431,888,371$1,365,896,351.54$23,302$2,095.81+$1431.87MSMPFF
6$49,959,117,824$48,426,997,267.62$29,150$3,237.93+$49959.09MSMPFF
7$2,633,704,046,807$2,580,247,790,734.69$37,536$5,121.41+$2633704.01MSMPFF
8$210,539,778,255,345$207,721,714,925,261.60$50,079$8,338.38+$210539778.21MSMPFF
9$25,583,415,744,018,936$25,358,138,181,285,710.00$69,753$14,065.80+$25583415743.95MSMPFF
10$4,732,920,065,047,615,000$4,705,545,810,201,515,000.00$102,337$24,771.77+$4732920065047.51MSMPFF

SMPFF vs ABBV: Complete Analysis 2026

SMPFFStock

San Miguel Food and Beverage, Inc. provides food and beverage products. The Food segment offers refrigerated processed and canned meat products under the Purefoods, Purefoods Tender Juicy, Star, Higante, Purefoods Beefies, Vida, Purefoods Nuggets, Veega, Ulam King, and San Miguel Del Mar brands; butter, margarine, cheese, milk, ice cream, jelly-based snacks and desserts, specialty oils, salad aids, snacks, and condiments under the Magnolia, Dari Crème, Star, and Cheezee brand names; flour mixes; coffee and coffee-related products; feeds under the B-Meg, B-Meg Premium, Integra, Expert, Dynamix, Essential, Pureblend, Bonanza, Jumbo, and Nutri Chunks brands; poultry and fresh meats under the Magnolia, Magnolia Chicken Stations, and Monterey brands; and flour and bakery ingredients, as well as provides poultry and livestock farming, grain terminal handling, franchising, and food services. The Beer and NAB segment provides fermented, malt-based, and non-alcoholic beverages. It offers beer under the San Miguel Pale Pilsen, Red Horse, Red Horse Super, San Mig Light, San Miguel Flavored Beer, San Miguel Super Dry, San Miguel Premium All-Malt, Cerveza Negra, San Mig Zero, San Mig Free, Gold Eagle, and San Miguel Cerveza Blanca brands; ready-to-drink tea under the Magnolia Healthtea brand; ready-to-drink juice under the Magnolia Fruit Drink brand; and sparkling malt-based non-alcoholic drink under the Cali brand. This segment also offers its products under the Valor, Blue Ice, Dragon, W1N Bia, Anker, Kuda Putih, Bruck, Knight, Agua Prima, and San Mig Cola brands. The Spirits segment provides gin, Chinese wine, brandy, rum, vodka, and other hard liquor under the Ginebra San Miguel, Vino Kulafu, Ginebra San Miguel Premium Gin Black, and Tondeña Manila Rum brands; and disinfectant alcohol under the San Miguel Ethyl Alcohol brand. The company was founded in 1925 and is based in Pasig, the Philippines. San Miguel Food and Beverage, Inc. is a subsidiary of San Miguel Corporation.

Full SMPFF Calculator →

ABBVHealthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Full ABBV Calculator →
📬

Get this SMPFF vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SMPFF vs SCHDSMPFF vs JEPISMPFF vs OSMPFF vs KOSMPFF vs MAINSMPFF vs JNJSMPFF vs MRKSMPFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.